| Donna Pettick, OTR/L | |
|
102 Arbor Rd, Summerville, SC 29485-5704 | |
| (843) 568-4786 | |
| (888) 965-4405 |
| Full Name | Donna Pettick |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 102 Arbor Rd, Summerville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235244211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6202 (South Carolina) | Primary |
| 225X00000X | Occupational Therapist | 1877 (New York) | Secondary |
| Provider Name | Ucpa Of Suffolk Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609964790 PECOS PAC ID: 8022907542 Enrollment ID: O20040312000828 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy.
› Verified 4 days ago
| Provider Name | Family Residences And Essential Enterprises Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093863565 PECOS PAC ID: 5890687453 Enrollment ID: O20040327000334 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Pettick, OTR/L 1235 Ashley Garden Blvd Unit 1622, Charleston, SC 29414-9219 Ph: (631) 339-3373 | Donna Pettick, OTR/L 102 Arbor Rd, Summerville, SC 29485-5704 Ph: (843) 568-4786 |
News Archive
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
A particular gene variant that could serve as a predictor for type 2 diabetes has been identified by researchers at UT Southwestern Medical Center.
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy.
› Verified 4 days ago
Jillian Bree Hunter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4015 2nd Ave Ste B, Summerville, SC 29486 Phone: 850-588-9641 Fax: 888-711-0441 | |
Suchita Prakash Bhayade, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 345 Salkahatchie St, Summerville, SC 29485 Phone: 843-810-6605 | |
Katherine Velez, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 835 S Main St, Summerville, SC 29483 Phone: 843-873-2372 | |
Corinne Rapier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 W 9th North St, Summerville, SC 29483 Phone: 843-879-0922 Fax: 855-232-8604 | |
Rachel Mink Spencer, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 202 Nexton Square Dr, Summerville, SC 29486 Phone: 854-429-4263 Fax: 843-767-8569 | |
Mrs. Elaina Novak, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4015 2nd Ave Ste B, Summerville, SC 29486 Phone: 803-929-7408 |